WHO ICTRP trial
A Placebo-Controlled Group Sequential Adaptive Treatment Assignment Study of…
EUCTR2006-003903-38-DE · EU Clinical Trials Register · Not Recruiting
Key facts
| Trial ID | EUCTR2006-003903-38-DE |
|---|---|
| Public title | A Placebo-Controlled Group Sequential Adaptive Treatment Assignment Study of Intravenous COL-144 (LY573144) in the Acute Treatment of Migraine |
| Scientific title | A Placebo-Controlled Group Sequential Adaptive Treatment Assignment Study of Intravenous COL-144 (LY573144) in the Acute Treatment of Migraine |
| Primary sponsor | CoLucid Pharmaceuticals, Inc. |
| Registry | EU Clinical Trials Register |
| Recruitment status | Not Recruiting |
| Study type | Interventional clinical trial of medicinal product |
| Countries | Finland;Germany;Netherlands |
| Conditions | Migraine MedDRA version: 8.1 Level: PT Classification code 10027599 Term: Migraine |
| Interventions | Product Name: COL-144 (LY573144; Eli Lilly & Company) Product Code: COL-144 Pharmaceutical Form: Intravenous infusion Current Sponsor code: COL-144 Other descriptive name: Benzamide… |
| Registration date | Aug 28, 2006 |
| Target size | 160 |
| Secondary IDs | COL MIG-201 |
| Registry page | clinicaltrialsregister.eu |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: